ATE398449T1 - Verwendung von azetidincarboxamidderivaten in therapie - Google Patents
Verwendung von azetidincarboxamidderivaten in therapieInfo
- Publication number
- ATE398449T1 ATE398449T1 AT04730286T AT04730286T ATE398449T1 AT E398449 T1 ATE398449 T1 AT E398449T1 AT 04730286 T AT04730286 T AT 04730286T AT 04730286 T AT04730286 T AT 04730286T AT E398449 T1 ATE398449 T1 AT E398449T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- therapy
- carboxamide derivatives
- azetidine carboxamide
- aryl
- Prior art date
Links
- PVXOUGHWLCBJOW-UHFFFAOYSA-N azetidine-1-carboxamide Chemical class NC(=O)N1CCC1 PVXOUGHWLCBJOW-UHFFFAOYSA-N 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0310057 | 2003-05-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE398449T1 true ATE398449T1 (de) | 2008-07-15 |
Family
ID=33397042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04730286T ATE398449T1 (de) | 2003-05-01 | 2004-04-29 | Verwendung von azetidincarboxamidderivaten in therapie |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20060276452A1 (de) |
| EP (1) | EP1617839B1 (de) |
| JP (1) | JP2006525297A (de) |
| KR (1) | KR20060017763A (de) |
| CN (1) | CN1780615A (de) |
| AT (1) | ATE398449T1 (de) |
| AU (1) | AU2004233644A1 (de) |
| BR (1) | BRPI0409959A (de) |
| CA (1) | CA2524245A1 (de) |
| DE (1) | DE602004014484D1 (de) |
| EA (1) | EA200501703A1 (de) |
| MX (1) | MXPA05011472A (de) |
| NO (1) | NO20055655L (de) |
| NZ (1) | NZ543322A (de) |
| WO (1) | WO2004096209A1 (de) |
| ZA (1) | ZA200508835B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0409938A (pt) * | 2003-05-01 | 2006-04-25 | Vernalis Res Ltd | derivados de azetidinacarboxamida e seu uso em terapia |
| CA2613235A1 (en) * | 2005-06-30 | 2007-01-11 | Prosidion Limited | Gpcr agonists |
| WO2007003961A2 (en) * | 2005-06-30 | 2007-01-11 | Prosidion Limited | Gpcr agonists |
| EP1986638A2 (de) * | 2006-02-21 | 2008-11-05 | Ampla Pharmaceuticals Inc. | Cb1-antagonisten und inverse agonisten |
| JP2010500300A (ja) | 2006-08-08 | 2010-01-07 | サノフィ−アベンティス | アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用 |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| RU2012111354A (ru) | 2009-08-26 | 2013-10-10 | Санофи | Новые кристаллические гидраты фторгликозидов, содержащие их фармацевтические препараты и их использование |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| WO2012120051A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683701B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683702B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683703B1 (de) | 2011-03-08 | 2015-05-27 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US11141404B1 (en) | 2020-11-18 | 2021-10-12 | Anebulo Pharmaceuticals, Inc. | Formulations and methods for treating acute cannabinoid overdose |
| AU2022362107A1 (en) * | 2021-10-11 | 2024-05-02 | Anebulo Pharmaceuticals, Inc. | Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4261990A (en) * | 1979-03-09 | 1981-04-14 | Ciba-Geigy Corporation | N-alkyleneiminoalkyl-dicarboximides as antiallergics and antiasthmatics |
| JPH03264562A (ja) * | 1989-05-22 | 1991-11-25 | Hokuriku Seiyaku Co Ltd | ピペリジン誘導体 |
| JP3194355B2 (ja) * | 1996-10-24 | 2001-07-30 | 宇部興産株式会社 | ピペリジン化合物及びその製法 |
| JP4542263B2 (ja) * | 1998-01-23 | 2010-09-08 | バーナリス リサーチ リミテッド | Ｃｎｓ障害を処置するためのアゼチジンカルボキサミド誘導体 |
| GB9917386D0 (en) * | 1999-07-23 | 1999-09-22 | Cerebrus Ltd | Chemical compounds-II |
| US6566356B2 (en) * | 2000-03-03 | 2003-05-20 | Aventis Pharma S.A. | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
| FR2805817B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation |
| FR2805810B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation |
| BRPI0409938A (pt) * | 2003-05-01 | 2006-04-25 | Vernalis Res Ltd | derivados de azetidinacarboxamida e seu uso em terapia |
-
2004
- 2004-04-29 MX MXPA05011472A patent/MXPA05011472A/es active IP Right Grant
- 2004-04-29 AU AU2004233644A patent/AU2004233644A1/en not_active Abandoned
- 2004-04-29 US US10/552,574 patent/US20060276452A1/en not_active Abandoned
- 2004-04-29 EP EP04730286A patent/EP1617839B1/de not_active Expired - Lifetime
- 2004-04-29 JP JP2006506193A patent/JP2006525297A/ja active Pending
- 2004-04-29 BR BRPI0409959-1A patent/BRPI0409959A/pt not_active IP Right Cessation
- 2004-04-29 EA EA200501703A patent/EA200501703A1/ru unknown
- 2004-04-29 CN CNA2004800117556A patent/CN1780615A/zh active Pending
- 2004-04-29 KR KR1020057020651A patent/KR20060017763A/ko not_active Ceased
- 2004-04-29 DE DE602004014484T patent/DE602004014484D1/de not_active Expired - Fee Related
- 2004-04-29 AT AT04730286T patent/ATE398449T1/de not_active IP Right Cessation
- 2004-04-29 CA CA002524245A patent/CA2524245A1/en not_active Abandoned
- 2004-04-29 NZ NZ543322A patent/NZ543322A/xx unknown
- 2004-04-29 WO PCT/GB2004/001812 patent/WO2004096209A1/en not_active Ceased
-
2005
- 2005-10-31 ZA ZA200508835A patent/ZA200508835B/en unknown
- 2005-11-30 NO NO20055655A patent/NO20055655L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1780615A (zh) | 2006-05-31 |
| NO20055655D0 (no) | 2005-11-30 |
| EP1617839A1 (de) | 2006-01-25 |
| AU2004233644A1 (en) | 2004-11-11 |
| MXPA05011472A (es) | 2005-12-12 |
| KR20060017763A (ko) | 2006-02-27 |
| DE602004014484D1 (de) | 2008-07-31 |
| EA200501703A1 (ru) | 2006-06-30 |
| JP2006525297A (ja) | 2006-11-09 |
| ZA200508835B (en) | 2006-12-27 |
| CA2524245A1 (en) | 2004-11-11 |
| NZ543322A (en) | 2009-03-31 |
| EP1617839B1 (de) | 2008-06-18 |
| BRPI0409959A (pt) | 2006-04-25 |
| WO2004096209A1 (en) | 2004-11-11 |
| US20060276452A1 (en) | 2006-12-07 |
| NO20055655L (no) | 2006-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE398449T1 (de) | Verwendung von azetidincarboxamidderivaten in therapie | |
| ATE453620T1 (de) | Azetidincarboxamid-derivate zur verwendung zur behandlung von cb1-rezeptor-vermittelten krankheiten | |
| EA200500018A1 (ru) | Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения | |
| IS8502A (is) | Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar | |
| EA200600223A1 (ru) | Замещённый 2-аминотетралины для лечения депрессии | |
| MXPA04009784A (es) | Tiazolidin-4-carbonitrilos y analogos y su uso como inhibidores de dipeptidil-peptidas. | |
| ATE440603T1 (de) | 8-hydroxychinolinderivate | |
| JO2282B1 (en) | Oxazole derivatives | |
| DE60305514D1 (de) | Neue verwendung von benzothiazolderivaten | |
| ATE384058T1 (de) | Thiazolderivate | |
| DE60045508D1 (de) | Dalda-analoge und ihre verwendung | |
| DK1458393T3 (da) | Substituerede diketopiperaziner som oxytocinantagonister | |
| DE602004015277D1 (de) | Substituierte-1-phthalazinamine als vr-1-antagonisten | |
| SE9902267D0 (sv) | New compounds | |
| RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
| MXPA05006271A (es) | Metodo para el tratamiento de desordenes del movimiento usando derivados de acido barbiturico. | |
| ATE293961T1 (de) | Verwendung von hydantoin und seinen derivaten gegen hypalbuminämie | |
| BRPI0517734A (pt) | derivados de 1-[(6,7-alcoxiquinoxalinil substituìdo) aminocarbonil]-4- (hetero) arilpiperazina | |
| ATE250027T1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| DE69902142D1 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| BG105469A (en) | Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration | |
| DK1280796T3 (da) | Pyrimidinyl-methyl-indol-derivater med antibakteriel aktivitet | |
| AU2003288107A1 (en) | Tiotropium-containing medicament combinations used for inhaling | |
| TW200511994A (en) | Novel compounds and therapeutic uses thereof | |
| UA91693C2 (ru) | Арилсульфонилметильные или арилсульфонамидные производные ароматических соединений, пригодные для лечения заболеваний, чувствительных к модулированию дофаминовых рецепторов d3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |